Direct and indirect costs of the Norwegian Breast Cancer Screening Program
AbstractNorway has had a nationwide, biennial public screening program for breast cancer since 2005. The program includes all women aged 50-69 years. The aim of this study was to estimate the total societal costs of one screening round. The cost analysis was based on the number women in the relevant age group, the proportions attending screening, estimated travel time to nearest mammography facility, and the proportion of women having repeat examination. Unit costs were taken from the DRG price list and other sources. The cost of mobile mammography units were based on cost accounts. The total costs of one screening round were estimated to be NOK 521 million (NOK 1,262 per woman attending screening), of which 64% were health care costs, and 36% were travel costs and productivity losses. The total costs of repeat examinations in one screening round for women with suspicious findings or inadequate quality on the screening mammograms were NOK 52.8 million (NOK 3,655 per woman reexamined). NOK 44.4 million of these costs may be due to false positive findings in the screening mammograms.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Oslo University, Health Economics Research Programme in its series HERO On line Working Paper Series with number 2012:3.
Length: 16 pages
Date of creation: 21 Nov 2012
Date of revision:
Contact details of provider:
Postal: HERO / Institute of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway
Phone: 2307 5309
Fax: 2307 5310
Web page: http://www.hero.uio.no/eng.html
More information through EDIRC
screening; mammograms; breast cancer;
Find related papers by JEL classification:
- H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
This paper has been announced in the following NEP Reports:
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Clarke, Philip M., 1998. "Cost-benefit analysis and mammographic screening: a travel cost approach," Journal of Health Economics, Elsevier, vol. 17(6), pages 767-787, December.
- Drummond, Michael F. & Sculpher, Mark J. & Torrance, George W. & O'Brien, Bernie J. & Stoddart, Greg L., 2005. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 3, number 9780198529453, September.
- Philip M. Clarke, 2002. "Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care," Health Economics, John Wiley & Sons, Ltd., vol. 11(2), pages 117-127.
- Godager, Geir, 2009. "Four Empirical Essays on the Market for General Practitioners' Services," HERO On line Working Paper Series 2009:7, Oslo University, Health Economics Research Programme.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Anbjørg Kolaas).
If references are entirely missing, you can add them using this form.